Cargando…

Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation

BACKGROUND: The usefulness of bronchodilators in coronavirus diseases 2019 (COVID-19) survivors is still uncertain, especially for patients with a concomitant obstructive lung disease. We aimed at verifying the level of bronchodilator reversibility in COVID-19 patients undergoing multidisciplinary p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniscalco, Mauro, Ambrosino, Pasquale, Fuschillo, Salvatore, Stufano, Silvia, Sanduzzi, Alessandro, Matera, Maria Gabriella, Cazzola, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041746/ https://www.ncbi.nlm.nih.gov/pubmed/33873099 http://dx.doi.org/10.1016/j.rmed.2021.106401

Ejemplares similares

Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients
por: Maniscalco, Mauro, et al.
Publicado: (2022)

Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients
por: Maniscalco, Mauro, et al.
Publicado: (2021)

Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
por: Maniscalco, Mauro, et al.
Publicado: (2022)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status
por: Moretta, Pasquale, et al.
Publicado: (2022)

Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate
por: Maniscalco, Mauro, et al.
Publicado: (2022)

COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings
por: Fuschillo, Salvatore, et al.
Publicado: (2021)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
por: Matera, Maria Gabriella, et al.
Publicado: (2016)

Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

Beyond Dual Bronchodilation – Triple Therapy, When and Why
por: Cazzola, Mario, et al.
Publicado: (2022)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017)

Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case Series
por: Balbi, Pietro, et al.
Publicado: (2022)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)

Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
por: Mormile, Mauro, et al.
Publicado: (2023)

Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

Cardiac and Pulmonary Rehabilitation: Two Underutilized Approaches with Some Unexpected Benefits
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

A Rapid Antigen Detection Test to Diagnose SARS-CoV-2 Infection Using Exhaled Breath Condensate by A Modified Inflammacheck(®) Device
por: Maniscalco, Mauro, et al.
Publicado: (2021)

COVID-19 and Post-Acute COVID-19 Syndrome: From Pathophysiology to Novel Translational Applications
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

COVID-19 and functional disability: current insights and rehabilitation strategies
por: Ambrosino, Pasquale, et al.
Publicado: (2020)

Deconditioning in COVID-19 survivors with reduced exercise performance: A role for endothelial dysfunction?
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

A Machine Learning Approach to Predict the Rehabilitation Outcome in Convalescent COVID-19 Patients
por: Adamo, Sarah, et al.
Publicado: (2022)

“Study on factors associated with post bronchodilator reversibility among patients presenting with dyspnea”
por: Vinod, VG
Publicado: (2023)

Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
por: Ahmed, Mona Ibrahim, et al.
Publicado: (2023)

Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life
por: Rossi, Andrea, et al.
Publicado: (2015)

Implementing Translational Research to Understand the Future of COVID-19 and Its Long-Term Consequences: A Degrowth Perspective or the Transformation of a Global Emergency?
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
por: Cazzola, Mario, et al.
Publicado: (2013)

Doxofylline is not just another theophylline!
por: Matera, Maria Gabriella, et al.
Publicado: (2017)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
por: Mosella, Marco, et al.
Publicado: (2018)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
por: Pascoe, Steven, et al.
Publicado: (2016)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with meta-regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g81au62b5fr5q9rdnqpgc9b8qb